Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed?

Mar 13, 2017, 10:42 AM by Michael Croft

Xconomy | This seems to be a watershed year for CAR-T therapy. The field's first-ever regulatory approval is looking like a strong possibility. However, the supercharged T cells remain an enigma.

March 13, 2017 | This seems to be a watershed year for CAR-T therapy. The field's first-ever regulatory approval is looking like a strong possibility. However, the supercharged T cells remain an enigma. Xconomy